Circadian research reveals promising combination therapy in preventing liver cancer
Recent research from the lab of Kristin Eckel-Mahan, PhD, associate professor in the Institute of Molecular Medicine’s Center for Metabolic and Degenerative Diseases, reveals how a standard therapy for hepatocellular carcinoma (HCC) combined with a natural molecule called nobiletin can…
NIH grant funds Houston Nutrition Obesity Research Center
The National Institutes of Health awarded a five-year, $5.9 million P30 grant to a collaborative team of investigators, including Kristin Eckel-Mahan, PhD, associate professor in the Center for Metabolic and Degenerative Diseases, to establish the Houston Nutrition Obesity Research Center…
Pages